Retraction
Silencing EGFR/HER3 signaling with a novel anti-EGFR domain II/IV antibody
Paper Information
Record ID:
7255
Author(s):
Journal:
Publication Date:
November 27, 2014
Retraction Date:
June 10, 2017
(8.4 years years ago)
Subjects:
Specific Fields:
Biology - Cancer Biology - Cellular Genetics Medicine - Drug Design Medicine - Oncology
Biology - Cancer Biology - Cellular Genetics Medicine - Drug Design Medicine - Oncology
Institutions:
- Translational Medicine Research Institute, International Joint Cancer Institute, The Second Military Medical University, Shanghai 200433, China
- Cancer Center, PLA General Hospital, PLA Postgraduate School of Medicine, 28 Fuxing Road, Beijing 100853, China
- Asian-Pacific Biosignatures Center, Tianjin Joint Academy of Biomedicine and Technology, Tianjin 300457, China
- Department of Anesthesiology, Jinling Hospital, School of Medicine, Nanjing University, Nanjing 210002, China
- School of Life Sciences, Tianjin University, Tianjin 300072, China
- Molecular Drug Discovery Center, Xi'an Jinwa Pharmaceutical Co., Ltd, Xi'an, Shaanxi 710000, China
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Elsevier
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.1016/j.canlet.2017.05.014Citations (3)
3
Total Citations2
Post-Retraction(66.7%)
1
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
2
Within 1 year
0
After 2+ years
288
Days since retraction (latest)
Paper citing Silencing EGFR/HER3 signaling with a novel anti-EG...
Unknown Authors
Unknown Journal
Published: Mar 2018
288 days after retraction
Paper citing Silencing EGFR/HER3 signaling with a novel anti-EG...
Unknown Authors
Unknown Journal
Published: Aug 2017
52 days after retraction
Paper citing Silencing EGFR/HER3 signaling with a novel anti-EG...
Unknown Authors
Unknown Journal
Published: Mar 2015
819 days before retraction
Quick Stats
Total Citations:
3
Years Since Retraction:
8.4 years
Open Access:
Yes
Last Checked:
Never